BBlogFlow

How a changing environment is reshaping mental health: international commission sets out a 10-year action plan - Africa Health Research Institute

·4d ago
Source: Africa Health Research Institute
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

An international commission of more than 20 experts is calling on governments, city authorities and research funders to make brain and mental health a standard measure of environmental, urban and climate policy. The Earth Brain Health Commission also sets a goal for the next decade: no major environmental intervention should be planned or evaluated without considering its effects on mental health. Its report is published in Nature Mental Health.

The commission finds that climate and weather extremes, air and noise pollution, urban stressors, biodiversity loss and widening social inequality are associated with increased risks of anxiety, depression, trauma-related disorders and cognitive decline. These exposures rarely occur in isolation. They cluster in the same places and populations, and act together through biological, psychological and social pathways across the life course, from prenatal development through old age.

This article is an excerpt. To read the full content, visit the original source. Africa Health Research Institute

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·